Current and novel therapeutic approaches in myelodysplastic syndromesJuly 22, 2014Leukemia, Myelodysplasia, Transplantation
The importance of hematologic, cytogenetic, and molecular testing and mutational analysis in chronic myeloid leukemiaMay 27, 2014Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Molecular monitoring and minimal residual disease in the management of chronic myelogenous leukemiaMay 27, 2014Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Current therapeutic options in hairy cell leukemiaMarch 27, 2014Leukemia, Myelodysplasia, TransplantationPatient & Survivor Care
Biomarker testing for treatment of metastatic colorectal cancer: role of the pathologist in community practiceFebruary 4, 2014GastroenterologyPatient & Survivor Care
Current options and future directions in the systemic treatment of metastatic melanomaFebruary 4, 2014MelanomaPatient & Survivor Care
Key issues in the management of gastrointestinal immune-related adverse events associated with ipilimumab administrationDecember 12, 2013MelanomaPatient & Survivor Care
A planning and evaluation program for assessing telecommunications applications in community radiation oncology programsDecember 11, 2013Patient & Survivor CareBusiness of Medicine
Use of the JAK1/JAK2 inhibitor ruxolitinib in the treatment of patients with myelofibrosisOctober 6, 2013Patient & Survivor Care
Minimizing cancer’s impact on bone with denosumab: current and future perspectivesSeptember 4, 2013Breast CancerGenitourinary CancerPatient & Survivor CareBusiness of Medicine
Complementary and alternative medicine (CAM) use in advanced cancer: a systematic reviewAugust 21, 2013Patient & Survivor Care
Continuous imatinib therapy in patients with gastrointestinal stromal tumorsAugust 13, 2013Gastroenterology
Practical considerations in the delivery of genetic counseling and testing services for inherited cancer predispositionJuly 3, 2013Patient & Survivor Care
